Kim, Su-Hyun
Choi, Moon Ki
Park, Na Young
Hyun, Jae-Won
Lee, Min Young
Kim, Ho Jin
Jung, Su Kyung
Cha, Yongjun
Article History
Received: 20 January 2020
Accepted: 14 April 2020
First Online: 14 May 2020
Competing interests
: Kim S.H. has received a grant from the National Cancer Center of Korea. Choi M.K. reports no financial disclosures. Park NY reports no financial disclosures. Hyun J.W. reports no financial disclosures. Lee M.Y. reports no financial disclosures. Kim H.J. has lectured, consulted, and received honoraria from Bayer Schering Pharma, Biogen, Genzyme, HanAll BioPharma, MedImmune, Merck Serono, Novartis, Teva-Handok, and UCB; received a grant from the Ministry of Science, ICT & Future Planning; and accepted research funding from Genzyme, Kael-GemVax, Merck Serono, Teva-Handok, and UCB; serves on a steering committee for MedImmune; is a co-editor for the Multiple Sclerosis Journal–Experimental, Translational, and Clinical, and an associated editor for the Journal of Clinical Neurology. Jung SK reports no financial disclosures. Cha Y. reports no financial disclosure.